Featured

MIS-C: The Impact of COVID-19 on the Pediatric Population

By: Erica Tonti, PharmD Candidate c/o 2022 Multisystem Inflammatory Syndrome in Children, or MIS-C, is a recent syndrome recognized by…

6 years ago

Transition of Care: A New and Emerging Pharmacy Specialty

By: Sami Barakat, PharmD. and Natalia Jucha, PharmD. Candidate c/o 2022              Since the publication of the Institute of Medicine…

6 years ago

Antibiotic Resistance: Why It’s Important to Educate the Future Generation & What I Learned from Doing So

By: Natalia Jucha PharmD Candidate c/o 2022              Due to the overuse and misuse of these medications, antibiotics are no…

6 years ago

Next Up in the World of Hyperlipidemia: Nexletlol TM

By: Preethi Samuel, Pharm.D. Candidate c/o of 2021              In the United States, at least one person has a heart…

6 years ago

A New Drug Class for Heart Failure—Dapagliflozin’s New Groundbreaking Indication for Heart Failure with Reduced Ejection Fraction (HFrEF)

By: Adrian Wong, PharmD Candidate c/o 2021 On May 5, 2020, the Food and Drug Administration (FDA) announced its approval…

6 years ago

Provider Status: What is it?

By: Katharine Russo, PharmD Candidate c/o 2021              As of July 1, 2000, the Accreditation Council for Pharmacy Education (ACPE)…

6 years ago

The Psychological impact of COVID-19 on Mental Health & Quality of Life

By: Shea Dorsey, PharmD Candidate c/o 2021            COVID-19 has taken a major toll on the mental wellbeing of people…

6 years ago

The State of Pharmacy Advocacy in New York

By: Jeremy Mesias, PharmD Candidate c/o 2022            As we begin another October, we mark the start of American Pharmacist…

6 years ago

New York State and Provider Status

By: Mah Noor, PharmD Candidate c/o 2021              Over the past decade, pharmacists across the nation have joined in a…

6 years ago

Pharmacists for Black Lives

By: Aiša Mrkulić , PharmD Candidate c/o 2022              In fulfilling our vow to uphold the Oath of a Pharmacist,…

6 years ago